IP Library Granted Patent US 10,106,625
Granted Patent B2
US 10,106,625 · App. 15/216,936 · Granted Oct 23, 2018

Pharmaceutical compositions with enhanced performance and improved processability

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,106,625
App. No.
15/216,936
Granted
Oct 23, 2018
Kind
B2
Abstract

The presently disclosed and claimed inventive concept(s) relates to a polymer for enhancing drug performance and improving processability. Specifically, the polymer comprises hydroxypropyl methyl cellulose acetate succinate (HPMC-AS). On the HPMC-AS, the percentage of total succinoyl degree of substitution is less than 12% at C6-OH position and greater than 53% at C3-OH, and the percentage of total acetyl degree of substitution is greater than 32% at C6-OH position.

Claims (9)

1. A method for making hydroxypropyl methyl cellulose acetate succinate (HPMC-AS) comprising the steps of:

(a) reacting an amount of acetic anhydride and sodium acetate with a reaction mixture of hydroxyl propyl methylcellulose and acetic acid at a reaction temperature in a range from about 85 to about 115° C.;

(b) maintaining the reaction temperature for a time from about 30 minutes to about 2.0 hours to allow reaction and thereby form an intermediate having a percentage of a total degree of substitution (DS) of acetyl greater than 32% at a C6-OH position (% C6DSAc>32%) of the intermediate; and

(c) reacting the intermediate with an amount of succinic anhydride at the reaction temperature for a time from about 2.5 hours to about 23.5 hours to allow reaction and thereby form HPMC-AS having a percentage of a total DS of succinoyl less than 12% at a C6-OH position (% C6DSSuc<12%) and greater than 53% at a C3-OH position (% C3DSSuc>53%).

2. The method of claim 1 , wherein the HPMC-AS has a percentage of a total DS of acetyl less than 27% at a C3-OH position (% C3DSAc<27%).

3. The method of claim 1 , wherein the time in step (c) is varied from 2.5 hours to 15.5 hours.

4. The method of claim 3 , wherein the time in step (c) is varied from 2.5 hours to 5.5 hours.

5. The method of claim 1 , wherein the temperature is in a range from 95 to 115° C.

6. The method of claim 1 , wherein the temperature is in a range from 95 to 110° C.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Jan 10, 2020
From: THE BANK OF NOVA SCOTIA
To: AVOCA LLC; HERCULES LLC; ISP INVESTMENTS LLC; PHARMACHEM LABORATORIES LLC
Reel/Frame 051557/0504 →
SECURITY AGREEMENT Recorded Jul 3, 2017
From: AVOCA, INC.; HERCULES LLC; ISP INVESTMENTS LLC; PHARMACHEM LABORATORIES, INC.
To: THE BANK OF NOVA SCOTIA, AS ADMINISTRATIVE AGENT
Reel/Frame 043084/0753 →
CHANGE OF NAME Recorded May 19, 2017
From: HERCULES INCORPORATED
To: HERCULES LLC
Reel/Frame 042503/0888 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 8, 2016
From: BRUGEL, TODD A.; NGUYEN, TUYEN T.
To: HERCULES INCORPORATED
Reel/Frame 039362/0490 →